These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 10066346

  • 1. Effects of cigarette smoking on Fas/Fas ligand expression of human lymphocytes.
    Suzuki N, Wakisaka S, Takeba Y, Mihara S, Sakane T.
    Cell Immunol; 1999 Feb 25; 192(1):48-53. PubMed ID: 10066346
    [Abstract] [Full Text] [Related]

  • 2. Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes.
    Büssing A, Stein GM, Pfüller U, Schietzel M.
    Anticancer Res; 1999 Feb 25; 19(3A):1785-90. PubMed ID: 10470116
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the expression of Fas, FasL and Bcl-2 in the pathogenesis of autoimmune thyroid disorders.
    Chen S, Fazle Akbar SM, Zhen Z, Luo Y, Deng L, Huang H, Chen L, Li W.
    Cell Mol Immunol; 2004 Jun 25; 1(3):224-8. PubMed ID: 16219172
    [Abstract] [Full Text] [Related]

  • 4. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
    Elsässer-Beile U, Gierschner D, Welchner T, Wetterauer U.
    Anticancer Res; 2003 Jun 25; 23(1A):433-7. PubMed ID: 12680244
    [Abstract] [Full Text] [Related]

  • 5. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression.
    Kaser A, Nagata S, Tilg H.
    Cytokine; 1999 Oct 25; 11(10):736-43. PubMed ID: 10525311
    [Abstract] [Full Text] [Related]

  • 6. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I, Veyrenc S, French LE, Brambilla C, Brambilla E.
    J Pathol; 2003 Oct 25; 201(2):268-77. PubMed ID: 14517844
    [Abstract] [Full Text] [Related]

  • 7. Balanced regulation of mRNA production for Fas and Fas ligand in lymphocytes from centenarians: how the immune system starts its second century.
    Pinti M, Troiano L, Nasi M, Bellodi C, Ferraresi R, Mussi C, Salvioli G, Cossarizza A.
    Circulation; 2004 Nov 09; 110(19):3108-14. PubMed ID: 15505087
    [Abstract] [Full Text] [Related]

  • 8. Apoptosis-related proteins (Fas, Fas ligand, bcl-2 and p53) in different types of human breast tumors.
    Ben-Hur H, Mordechay E, Halperin R, Gurevich P, Zandbank J, Herper M, Zusman I.
    Oncol Rep; 2002 Nov 09; 9(5):977-80. PubMed ID: 12168058
    [Abstract] [Full Text] [Related]

  • 9. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL.
    Clin Cancer Res; 2002 Oct 09; 8(10):3137-45. PubMed ID: 12374681
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
    Blanco-Colio LM, Muñoz-García B, Martín-Ventura JL, Lorz C, Díaz C, Hernández G, Egido J.
    Circulation; 2003 Sep 23; 108(12):1506-13. PubMed ID: 12952848
    [Abstract] [Full Text] [Related]

  • 13. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
    Gastman BR, Atarshi Y, Reichert TE, Saito T, Balkir L, Rabinowich H, Whiteside TL.
    Cancer Res; 1999 Oct 15; 59(20):5356-64. PubMed ID: 10537320
    [Abstract] [Full Text] [Related]

  • 14. ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family.
    Di Renzo M, Rubegni P, Sbano P, Cuccia A, Castagnini C, Pompella G, Pasqui AL, Capecchi PL, Auteri A, Laghi Pasini F, Fimiani M.
    Arch Dermatol Res; 2003 Sep 15; 295(5):175-82. PubMed ID: 12883827
    [Abstract] [Full Text] [Related]

  • 15. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X, Hazarika P, Zhang C, Talpur R, Duvic M.
    Clin Cancer Res; 2001 Sep 15; 7(9):2682-92. PubMed ID: 11555580
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of apoptosis markers in the retinas of human subjects with diabetes.
    Abu-El-Asrar AM, Dralands L, Missotten L, Al-Jadaan IA, Geboes K.
    Invest Ophthalmol Vis Sci; 2004 Aug 15; 45(8):2760-6. PubMed ID: 15277502
    [Abstract] [Full Text] [Related]

  • 20. Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells.
    Brás A, Albar JP, Leonardo E, de Buitrago GG, Martínez-A C.
    Cell Death Differ; 2000 Mar 15; 7(3):262-71. PubMed ID: 10745271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.